- Nov 23, 2024 (Saturday)
HALL A - Nov 23, 2024 (Saturday)
HALL B - Nov 24, 2024 (Sunday)
HALL A - Nov 24, 2024 (Sunday)
HALL B
|
23rd November 2024, Saturday |
||
|
Hall A | Oncology |
||
|
Time (IST) |
Topic |
Speaker / Panelist / Chairperson |
|
08:00 AM – 09:00 AM |
Session 1: Oral Paper Session A |
6 papers |
|
Judges |
Shruti Kakkar, Leni Mathew, Revathi Raj |
|
|
09:00 AM – 10:35 AM |
Session 2: Acute Lymphoblastic Leukemia |
|
|
Chairpersons |
Shabab Lalit, Faisal Guru, Romesh Khajuria |
|
|
09:00 AM – 09:20 AM |
Improvise or Intricate the risk stratification of B cell ALL – Role of NGS and newer tools |
Gaurav Narula |
|
09:20 AM – 09:40 AM |
What has the last decade taught me about upfront management of B cell ALL? |
Vaskar Saha |
|
09:40 AM – 10:00 AM |
Blina (B) and Ino (I) – Bewildering and Innovative or Brawny and Intense |
Revathi Raj |
|
10:00 AM – 10:25 AM |
Novel insights into the management of the T cell ALL |
David Teachey |
|
10:25 AM - 10:35 AM |
Discussion |
|
|
10:35 AM - 11:15 AM |
Session 3: Brain Tumors |
|
|
Chairpersons |
Ritu Lamichhane, Rajeev Gupta, Deepak Abrol |
|
|
10:35 AM – 10:55 AM |
Traversing this era of molecular pathways to a humbling Indian experience – The story of Medulloblastoma |
Rakesh Jalali |
|
10:55 AM – 11:15 AM |
Precision, de-escalation, maintenance – what really works? Current insights into managing Medulloblastoma |
Girish Chinnaswamy |
|
11:15 AM – 11:30 AM |
TEA BREAK |
|
|
11:30 AM – 11:45 AM |
R K Marwaha Best SIOP Paper |
Chairpersons: |
|
Vincristine And Topotecan Versus Carboplatin, Etoposide And Vincristine Based Chemotherapy For Ocular Salvage In Group D And Group E Intraocular Retinoblastoma: A Randomized, Comparative Trial |
Prashant Prabhakar |
|
|
11:45 AM – 12:30 PM |
Inauguration |
|
|
12:30 PM – 01:30 PM |
PHO Oration |
Chairpersons: |
|
How I have chosen my research Topics and what has it Taught Me? |
Sameer Bakhshi |
|
|
01:30 PM – 02:15 PM |
LUNCH |
|
|
02:15 PM - 04:00 PM |
Session 3: Brain Tumors (Continued) |
|
|
Chairpersons |
Shweta Bansal, Ratna Sharma, Manmeet Sodhi |
|
|
02:15 PM – 02:40 PM |
The struggle for better survival – infant Medulloblastoma and other embryonal tumors |
Santhosh Upadhyaya |
|
02:40 PM – 03:05 PM |
Targeted therapy in low grade glioma |
Santhosh Upadhyaya |
|
03:05 PM – 03:50 PM |
Panel discussion: |
Moderator: |
|
03:50 PM - 04:00 PM |
Discussion |
|
|
04:00 PM – 05:00 PM |
INPHOG Studies |
Nishant Verma , Girish Chinnaswamy |
|
04:00 PM - 04:15 PM |
Integrated Clinico-Pathological And Treatment Outcome Analysis Of Extra-Cranial Malignant Germ Cell Tumors In Children And Adolescents In India: A Retrospective Multi-Centric Study |
Sonali Mohapatra |
|
04:15 PM - 04:30 PM |
The INPHOG Childhood Cancer Survivorship (C2S) Study: Making of the Indian Childhood Cancer Survivorship Cohort |
Rachna Seth |
|
04:30 PM - 04:45 PM |
Factors Impacting Abandonment In Patients With Newly Diagnosed Retinoblastoma: Analysis From Inphog-Rb-19-01 Study |
Amita Mahajan |
|
04:45 PM - 05:00 PM |
Preliminary Data From A Multicentric Prospective Study On Paediatric Rare Tumours From India |
Maya Prasad |
|
05:00 PM - 05:15 PM |
TEA BREAK |
|
|
05:15 PM - 06:30 PM |
Session 4: Sarcoma |
|
|
Chairpersons |
Prachi Jain, Ratnakar Sharma, Sandeep Kaur |
|
|
05:15 PM – 05:30 PM |
RMS – VAC ‘all’ or improvise? |
Rikki John |
|
05:30 PM – 05:45 PM |
NRSTS – 3 cases that taught me the most |
Sameer Rastogi |
|
05:45 PM – 06:30 PM |
Panel Discussion: |
Moderator: |
|
06:30 PM – 07:30 PM |
GBM |
|
|
23rd November 2024, Saturday |
||
|
Hall B | Hematology |
||
|
Time (IST) |
Topic |
Speaker / Panelist / Chairperson |
|
08:00 AM – 09:00 AM |
Session 1: Oral Paper Session B |
6 papers |
|
Judges |
Vineeta Gupta, Nita Radhakrishnan, Shweta Bansal |
|
|
09:00 AM – 10:35 AM |
Session 2: Hemoglobinopathy |
|
|
Chairpersons |
Pankaj Abrol, Ashok Gupta, Muzafar Jan |
|
|
09:00 AM – 09:15 AM |
Unique in its own ways – Eβ thalassemia |
Pritam Singha Roy |
|
09:15 AM – 09:30 AM |
New Horizons in The Treatment of Adult B-Thal Patients’ |
Ratna Sharma |
|
09:30 AM – 09:50 AM |
Curing Sting, Suffering, Sepsis in Sickle |
Niketa Shah |
|
09:50 AM – 10:25 AM |
Panel Discussion: |
Moderator: |
|
10:25 AM - 10:35 AM |
Discussion |
|
|
10:35 AM - 11:15 AM |
Session 3: Thrombosis and MAHA |
|
|
Chairpersons |
Siyaram Didel, Alka Yadav, Rajeev K Gupta |
|
|
10:35 AM – 10:55AM |
DEBATE |
DOAC - Richa Jain |
|
10:55 AM – 11:10 AM |
Case based teaching: APLA, Neonatal thrombosis, Thrombophilia |
Nita Radhakrishnan |
|
11:10 AM - 11:15 AM |
Discussion |
|
|
11:15 AM – 11:30 AM |
TEA BREAK |
|
|
11:30 AM – 11:45 AM |
R K Marwaha Best SIOP Paper (Hall A) |
Chairpersons: |
|
Vincristine And Topotecan Versus Carboplatin, Etoposide And Vincristine Based Chemotherapy For Ocular Salvage In Group D And Group E Intraocular Retinoblastoma: A Randomized, Comparative Trial |
Prashant Prabhakar |
|
|
11:45 AM – 12:30 PM |
Inauguration (Hall A) |
|
|
12:30 PM – 01:30 PM |
PHO Oration (Hall A) |
Chairpersons: |
|
How I have chosen my research Topics and what has it Taught Me? |
Sameer Bakhshi |
|
|
01:30 PM – 02:15 PM |
LUNCH |
|
|
02:15 PM - 04:00 PM |
Session 4: Endotheliopahthies |
|
|
Chairpersons |
Sani Sipai, Satya P Yadav, Fayaz Wani |
|
|
02:15 PM – 02:35 PM |
Fixing bumps on the road – managing TTP in resource limited setting |
Sirisha Rani |
|
02:35 PM – 03:00 PM |
What West does not know – aHUS |
Vinay M V |
|
03:00 PM – 03:45 PM |
Panel Discussion |
Moderator: |
|
03:45 PM - 04:00 PM |
Discussion |
|
|
04:00 PM – 05:00 PM |
INPHOG Studies (Hall A) |
Nishant Verma , Girish Chinnaswamy |
|
04:00 PM - 04:15 PM |
Integrated Clinico-Pathological And Treatment Outcome Analysis Of Extra-Cranial Malignant Germ Cell Tumors In Children And Adolescents In India: A Retrospective Multi-Centric Study |
Sonali Mohapatra |
|
04:15 PM - 04:30 PM |
The INPHOG Childhood Cancer Survivorship (C2S) Study: Making of the Indian Childhood Cancer Survivorship Cohort |
Rachna Seth |
|
04:30 PM - 04:45 PM |
Factors Impacting Abandonment In Patients With Newly Diagnosed Retinoblastoma: Analysis From INPHOG-RB-19-01 Study |
Amita Mahajan |
|
04:45 PM - 05:00 PM |
Preliminary Data From A Multicentric Prospective Study On Paediatric Rare Tumours From India |
Maya Prasad |
|
05:00 PM - 05:15 PM |
TEA BREAK |
|
|
05:15 PM - 06:30 PM |
Session 5: Inborn errors of immunity |
|
|
Chairpersons |
Gaurav Kharya, Suraj Gupte, Subhash Singh Slathia |
|
|
05:15 PM – 05:45 PM |
Treading cautiously – Haploidentical transplant for IEI |
Mary Slatter |
|
05:45 PM – 06:30 PM |
Panel Discussion: |
Moderator: |
|
06:30 PM – 07:30 PM |
GBM |
|
|
24th November 2024, Sunday |
||
|
Hall A | Oncology |
||
|
Time (IST) |
Topic |
Speaker / Panelist / Chairperson |
|
08:00 AM – 09:00 AM |
Session 1: Oral Paper Session C |
|
|
Judges |
Shailesh Kanvinde, Archana Kumar, Reghu K S |
|
|
09:00 AM – 09:45 AM |
Session 2: Meet the Experts (Common) |
|
|
1. Relapsed ALL (Early B, Late B) |
1.David Teachey/Scott Howard/Shripad Banavali |
|
|
10:00 AM - 11:00 AM |
Session 3: Hodgkin Lymphoma |
|
|
Chairpersons |
Shailesh Kanvinde, Nalini Pati, Manmeet Sodhi |
|
|
10:00 AM – 10:20 AM |
Emerging therapy for newly diagnosed Hodgkin Lymphoma – lessons from adult colleagues |
Amita Mahajan |
|
10:20 AM – 10:40 AM |
Don’t give up – Relapsed / Refractory HL – Options in the current era |
Shyam Srinivasan |
|
10:40 AM – 10:55 AM |
Response assessment- PET scan for clinicians |
Vasudev Bhat |
|
10:55 AM - 11:00 AM |
Discussion |
|
|
11:00 AM – 11:15 AM |
TEA BREAK |
|
|
11:15 AM - 12:25 PM |
Session 4: Supportive care |
|
|
Chairpersons |
Chandra Mohan, Khurshid A Wani, Bishow Nath Adhikari, Ravinder K Gupta |
|
|
11:15 AM – 11:30 AM |
Hope and healing – Transforming childhood cancer care through community support |
Poonam Bagai |
|
11:30 AM – 11:50 AM |
Advancing nutrition science in childhood cancer through multinational collaborations |
Elena J Ladas |
|
11:50 AM – 12:08 PM |
DEBATE – 1 |
For - Payal Malhotra |
|
12:08 PM – 12:25 PM |
DEBATE – 2 |
For - Jyothi M |
|
12:25 PM - 12:30 PM |
Discussion |
|
|
12:30 PM - 01:30 PM |
Session 5: Germ cell tumors |
|
|
Chairpersons |
Sunil Jondhale, Reghu K S, Reema Khajuria |
|
|
12:30 PM – 12:55 PM |
Germ cell tumors- The MaGIC of collaboration |
Farzana Parshankar |
|
12:55 PM – 01:30 PM |
Panel Discussion: |
Moderator: |
|
Discussion |
||
|
01:30 PM – 02:15 PM |
LUNCH BREAK |
|
|
02:15 PM - 03:30 PM |
Session 6: Do Dreams come true? |
|
|
Chairpersons |
Scott Howard, Sarita Verma, Seema Gupta |
|
|
02:15 PM – 02:35 PM |
A uniform Cancer registry in India – An arduous task |
Ramandeep Arora |
|
02:35 PM – 02:50 PM |
Modern day radiotherapy for peadtric cancers |
Ashutosh Gupta |
|
02:50 PM – 03:10 PM |
Dinutuximab and DFMO – Will the magic work? |
Sandeep Jain |
|
03:10 PM – 03:30 PM |
Managing energy to guarantee a great career and life |
Scott Howard |
|
TEA BREAK |
||
|
03:40 PM – 04:40 PM |
QUIZ |
Quiz Masters - |
|
04:40 PM – 05:00 PM |
Valedictory Function |
|
|
24th November 2024, Sunday |
||
|
Hall B | Hematology |
||
|
Time (IST) |
Topic |
Speaker / Panelist / Chairperson |
|
08:00 AM – 09:00 AM |
Session 1: Oral Paper Session D |
|
|
Judges |
Rasmi Palassery, Ponni Sivaprakasam, Nalini Pati |
|
|
09:00 AM – 09:45 AM |
Session 2: Meet the Experts (Common) |
|
|
1. Relapsed ALL (Early B, Late B) |
1. David Teachey/Scott Howard/Shripad Banavali |
|
|
10:00 AM - 11:00 AM |
Session 3: IBMFS |
|
|
Chairpersons |
Archana Kumar, Vineeta Gupta, Subhash Bhardwaj |
|
|
10:00 AM – 10:15 AM |
Has the knowledge of genetics changed my practice of pediatric hematology ? |
Anand Prakash |
|
10:15 AM – 10:30 AM |
Medical treatment for Fanconi Anemia- Is it worth a try? |
Gayathri Sajeevan |
|
10:30 AM – 10:45 AM |
HSCT for Fanconi Anemia in India – Tips for transplanters |
Satya P Yadav |
|
10:45 AM – 11:00 AM |
ADA deficiency- Spectrum and treatment approach |
Veerendra Patil |
|
11:00 AM – 11:15 AM |
TEA BREAK |
|
|
11:15 AM - 12:25 PM |
Session 4: Something old-something new in Hematology |
|
|
Chairpersons |
J S Arora, Gitika Pant, Irm Yasmeen |
|
|
11:15 AM – 11:30 AM |
Have fought my battles but it’s far from over |
Shobha Tuli |
|
11:30 AM – 11:45 AM |
Current status of Gene therapy for thalassemia |
Siddharth Totadri |
|
11:45 AM – 12:05 PM |
DEBATE |
IST- Mukesh Dhankar |
|
12:05 PM – 12:25 PM |
DEBATE |
Transfusion therapy - Archana MV |
|
12:25 PM - 12:30 PM |
Discussion |
|
|
12:30 PM - 01:30 PM |
Session 5: Hemophilia |
|
|
Chairpersons |
K Koul, Kanwaljeet Kaur, Aleem Jan |
|
|
12:30 PM – 12:55 PM |
Changing life of a person with hemophilia – |
Nidhi Bhatt |
|
12:55 PM – 01:30 PM |
Panel Discussion: |
Moderator: |
|
01:30 PM - 01:45 PM |
Alternate donor transplant in Thalassemia - Current Status in India |
Sunil Bhat |
|
01:45 PM – 02:15 PM |
LUNCH BREAK |
|
|
02:15 PM - 03:30 PM |
Session 6: |
|
|
Chairpersons: |
Raj Warrier, Vinod Kumar, G. S. Saini |
|
|
02:15 PM – 02:35 PM |
CRISPR in sickle and others- exciting times ahead? |
Gaurav Kharya |
|
02:35 PM – 02:50 PM |
Difficult hematology consults (case based) |
Shweta Bansal |
|
02:50 PM – 03:10 PM |
Beyond GCSF in SCN |
Shivani Patel |
|
03:10 PM – 03:40 PM |
Impact of extended half life factor in Hemophilia care |
Varun Kaul |
|
TEA BREAK |
||
|
03:40 PM – 04:40 PM |
QUIZ (Hall A) |
Quiz masters: |
|
04:40 PM – 05:00 PM |
Valedictory Function (Hall A) |
|